Company Filing History:
Years Active: 2025
Title: Zhifeng Long: Innovator in mRNA Vaccine Technology
Introduction
Zhifeng Long is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of mRNA vaccines. His work is crucial in the fight against infectious diseases, including the novel coronavirus.
Latest Patents
Zhifeng Long holds a patent for "Compositions and methods of mRNA vaccines against novel coronavirus infection." This patent describes a ribonucleic acid (RNA) encoding a spike (S) protein or an immunogenic fragment of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The invention includes at least one non-naturally occurring amino acid mutation, with some embodiments derived from a delta variant. The patent also covers relevant polynucleotides, vectors, cells, compositions, kits, production methods, and methods of use. He has 1 patent to his name.
Career Highlights
Zhifeng Long is associated with Rnaimmune, Inc., where he continues to advance research in mRNA technology. His innovative approach has positioned him as a key player in the biotechnology sector, particularly in vaccine development.
Collaborations
Zhifeng Long has collaborated with notable colleagues, including Neeti Ananthaswamy and Yong-Sik Bong. These partnerships enhance the research and development efforts in the field of mRNA vaccines.
Conclusion
Zhifeng Long's contributions to mRNA vaccine technology are vital in addressing global health challenges. His innovative work continues to pave the way for advancements in vaccine development and infectious disease prevention.